Generic drugs occupy 41% of antidiabetics market in 9 mths
By Kim, Jin-Gu | translator Alice Kang
23.01.19 06:20:07
가나다라
0
Prescription amount of Galvus generics recored KRW 14.5 billion last year... share rises to 41% of the market
Tenelia generic’s share increases to 32% in only 2 months of launch...expected to bring full-scale competition in the market
The market share held by generic versions of the original Galvus (vildagliptin) that were launched after the patent expiry of the original drug in March last year increased to 41% at the end of last year. The market share held by generic versions of Tenelia (teneligliptin), which 37 companies jumped in to manufacture, increased to 32% only two months after its release.
◆Market share of Galvus generics increase to 41%...Kyongbo and Hanmi shows greatest advances
According to the market research institution UBIST on the 19th, the total out
Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)